#BEGIN_DRUGCARD DB02188

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C35H39CuN4O4

# Chemical_IUPAC_Name:
(1R,22S)-5,9-bis(2-carboxyethyl)-14,19-diethyl-4,10,15,20,22-pentamethyl-2$l^{5},22,23$l^{5},25-tetraaza-1-cupraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2(6),3(24),4,7,9,11,13(23),14,16,18,20-undecaen-22-ium-2,23-bis(ylium)

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-Methylmesoporphyrin Containing Copper

# HET_ID:
MP1

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C35H40N4O4.Cu/c1-8-22-18(3)28-17-33-23(9-2)21(6)32(39(33)7)16-27-20(5)25(11-13-35(42)43)31(38-27)15-30-24(10-12-34(40)41)19(4)26(36-30)14-29(22)37-28;/h14-17H,8-13H2,1-7H3,(H3,36,37,38,40,41,42,43);/q;+4/p-1/b26-14-,27-16-,28-17-,29-14-,30-15-,31-15-,32-16-,33-17-;

# InChI_Key:
InChIKey=RDSHXUIGVQAIDP-ZHZUXMKXSA-M

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2188

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
643.255

# Molecular_Weight_Mono:
642.226731835

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1C9E

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.03

# Predicted_LogS:
-5.9

# Predicted_Water_Solubility:
9.06e-04 g/l

# Primary_Accession_No:
DB02188

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5162683

# PubChem_Substance_ID:
46505158

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02216

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCC1=C(C)C2=CC3=C(CC)C(C)=C4C=C5C(C)=C(CCC(O)=O)C6=[N+]5[Cu@@]5(N7C(=CC1=[N+]25)C(C)=C(CCC(O)=O)C7=C6)[N@+]34C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:53 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M97208

# Drug_Target_1_GenBank_ID_Protein:
143044

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hemH

# Drug_Target_1_Gene_Sequence:
>933 bp
GTGAGTAGAAAGAAAATGGGGCTTCTCGTGATGGCGTACGGCACGCCTTATAAGGAAGAA
GATATTGAACGTTATTATACACATATCAGAAGAGGCAGAAAGCCTGAACCTGAAATGCTT
CAAGATTTGAAAGACAGATACGAAGCGATTGGCGGCATTTCACCGCTTGCCCAAATCACA
GAACAGCAGGCGCATAATCTGGAACAGCACTTGAATGAAATTCAGGATGAGATTACGTTT
AAAGCGTATATCGGACTGAAGCATATCGAGCCGTTTATTGAAGACGCCGTAGCAGAGATG
CATAAGGATGGCATTACAGAAGCAGTCAGCATCGTGCTGGCGCCGCATTTCTCCACGTTC
AGCGTTCAGTCCTACAACAAACGCGCCAAAGAAGAGGCTGAAAAACTCGGCGGCTTAACG
ATTACGTCAGTTGAAAGCTGGTACGATGAACCGAAGTTCGTGACATATTGGGTTGACCGA
GTGAAGGAAACATATGCGTCAATGCCTGAGGATGAAAGAGAAAACGCAATGCTCATCGTA
TCCGCACACAGCCTGCCGGAAAAAATCAAAGAATTTGGAGACCCGTACCCGGACCAGCTT
CATGAATCGGCGAAATTAATTGCTGAAGGCGCAGGCGTTTCCGAATATGCTGTCGGCTGG
CAAAGTGAAGGGAACACGCCTGATCCTTGGCTCGGACCCGATGTTCAGGATTTAACACGT
GATTTATTCGAACAAAAAGGCTATCAAGCATTTGTATATGTTCCTGTTGGGTTTGTCGCG
GATCACTTAGAAGTGCTTTATGATAATGATTATGAATGCAAAGTGGTTACTGACGATATC
GGCGCAAGCTATTACCGGCCGGAAATGCCAAATGCCAAGCCTGAATTTATTGATGCTTTG
GCAACAGTCGTATTAAAAAAATTAGGACGTTAA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
10704318	Lecerof D, Fodje M, Hansson A, Hansson M, Al-Karadaghi S: Structural and mechanistic basis of porphyrin metallation by ferrochelatase. J Mol Biol. 2000 Mar 17;297(1):221-32.
1459957	Hansson M, Hederstedt L: Cloning and characterization of the Bacillus subtilis hemEHY gene cluster, which encodes protoheme IX biosynthetic enzymes. J Bacteriol. 1992 Dec;174(24):8081-93.
9141132	Hansson M, Gough SP, Brody SS: Structure prediction and fold recognition for the ferrochelatase family of proteins. Proteins. 1997 Apr;27(4):517-22.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9384565	Al-Karadaghi S, Hansson M, Nikonov S, Jonsson B, Hederstedt L: Crystal structure of ferrochelatase: the terminal enzyme in heme biosynthesis. Structure. 1997 Nov 15;5(11):1501-10.
9579061	Noback MA, Holsappel S, Kiewiet R, Terpstra P, Wambutt R, Wedler H, Venema G, Bron S: The 172 kb prkA-addAB region from 83 degrees to 97 degrees of the Bacillus subtilis chromosome contains several dysfunctional genes, the glyB marker, many genes encoding transporter proteins, and the ubiquitous hit gene. Microbiology. 1998 Apr;144 ( Pt 4):859-75.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2391

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
35348

# Drug_Target_1_Name:
Ferrochelatase

# Drug_Target_1_Number_of_Residues:
310

# Drug_Target_1_PDB_ID:
1LD3

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00762	Ferrochelatase

# Drug_Target_1_Protein_Sequence:
>Ferrochelatase
MSRKKMGLLVMAYGTPYKEEDIERYYTHIRRGRKPEPEMLQDLKDRYEAIGGISPLAQIT
EQQAHNLEQHLNEIQDEITFKAYIGLKHIEPFIEDAVAEMHKDGITEAVSIVLAPHFSTF
SVQSYNKRAKEEAEKLGGLTITSVESWYDEPKFVTYWVDRVKETYASMPEDERENAMLIV
SAHSLPEKIKEFGDPYPDQLHESAKLIAEGAGVSEYAVGWQSEGNTPDPWLGPDVQDLTR
DLFEQKGYQAFVYVPVGFVADHLEVLYDNDYECKVVTDDIGASYYRPEMPNAKPEFIDAL
ATVVLKKLGR

# Drug_Target_1_Reaction:
protoheme + 2 H+ = protoporphyrin + Fe2+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the ferrous insertion into protoporphyrin IX

# Drug_Target_1_SwissProt_ID:
P32396

# Drug_Target_1_SwissProt_Name:
HEMH_BACSU

# Drug_Target_1_Synonyms:
EC 4.99.1.1
Heme synthetase
Protoheme ferro-lyase

# Drug_Target_1_Theoretical_pI:
4.54

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02188
